Author: Gabriel
05
May | 2022
CNBX Pharmaceuticals Granted Patent in Hong Kong
TEL AVIV, Israel and BETHESDA, Md., May 5, 2022 CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer related cannab
28
March | 2022
Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals
TEL AVIV, Israel and BETHESDA, Md., March 28, 2022 Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of cancer relate